Article

Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein Farnesyltransferase

Department of Biochemistry, Duke University Medical Center, Box 3711, Durham, NC 27710, USA.
Chemistry & biology (Impact Factor: 6.59). 03/2009; 16(2):181-92. DOI: 10.1016/j.chembiol.2009.01.014
Source: PubMed

ABSTRACT Protein farnesyltransferase (FTase) catalyzes an essential posttranslational lipid modification of more than 60 proteins involved in intracellular signal transduction networks. FTase inhibitors have emerged as a significant target for development of anticancer therapeutics and, more recently, for the treatment of parasitic diseases caused by protozoan pathogens, including malaria (Plasmodium falciparum). We present the X-ray crystallographic structures of complexes of mammalian FTase with five inhibitors based on an ethylenediamine scaffold, two of which exhibit over 1000-fold selective inhibition of P. falciparum FTase. These structures reveal the dominant determinants in both the inhibitor and enzyme that control binding and selectivity. Comparison to a homology model constructed for the P. falciparum FTase suggests opportunities for further improving selectivity of a new generation of antimalarial inhibitors.

Download full-text

Full-text

Available from: Steven Fletcher, Dec 17, 2013
0 Followers
 · 
133 Views
Show more